Type 2 Diabetes Trial, By Invitation NCT06768177 Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, By Invitation

NCT06768177
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People with moderate to severe erectile dysfunction, based on a specific questionnaire score below 17 (called the IIEF-5 score).
  • People who have already tried at least two types of previous treatments for erectile dysfunction without success.
  • People who have had nerve-sparing surgery in the pelvic area (such as prostate surgery).
  • People whose blood pressure is well controlled with medication.
  • People whose diabetes is well managed with medication.
  • People who currently smoke or have smoked in the past.
  • People who have good kidney function, even if taking medication.
  • People whose high triglyceride and/or high cholesterol levels are well controlled, even if taking medication.
  • People with a body mass index (a measure of body weight relative to height) of 35 or below.
  • People with normal blood levels of certain hormones related to sexual and thyroid function (FSH, LH, PRL, Total Testosterone, and TSH).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently taking antidepressants, anti-anxiety medications, sedatives, or antipsychotic medications.
  • People who consume more than 500 grams of alcohol per day.
  • People with a body mass index above 35.
  • People with abnormal blood levels of certain hormones related to sexual and thyroid function (FSH, LH, PRL, Total Testosterone, and TSH).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Registry
ClinicalTrials.gov
Start date
1 April 2023
Est. completion
1 November 2024

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in erectile function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov